We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

BMS Receives FDA Breakthrough Therapy Designation for Chronic Hepatitis C Treatment

News   Feb 26, 2014

 
BMS Receives FDA Breakthrough Therapy Designation for Chronic Hepatitis C Treatment
 
 
Advertisement
 

RELATED ARTICLES

Alcohol Consumption Blocks a Chemical That Promotes Attention

News

A new study shows that the brain activity of those under the influence of alcohol may be affected by brain chemistry.

READ MORE

Trial Results Address Concerns About Pharmacogenetic Testing

News

Some laboratories now offer pharmacogenetic tests that allow patients to learn whether they carry genetic variants known to be associated with adverse drug effects. But there have been concerns. A new paper published in JAMA Network Open might help allay some of these concerns.

READ MORE

Peanut Allergy Treatment Shown To Significantly Reduce Risk of Life-Threatening Reactions

News

After one year of treatment, almost 80 percent of study participants were able to eat 15 peanuts without a reaction.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE